Previous studies show p-AKT can directly promote the degradation of p53 protein by nuclear MDM2 and downregulate the activity of p53, resulting in an imbalanced microenvironment that promotes cancer cell proliferation but inhibits apoptosis (35, 36). This evidence concerns the gene MDM2 and cancer.